PAD4-IN-2 TFA: From Targeting to Assay Design

2026-09-10

PAD4-IN-2 TFA, also known as Compound 5i TFA, connects tumor-directed uptake with PAD4-H3cit-NET biology. This guide explains how to interpret its enzymatic, cellular, immune, and in vivo data without confusing pathway inhibition with direct cytotoxicity.

SAG and Developmental Biology: A Dose-to-Design Guide

2026-09-10

SAG is more than a Hedgehog pathway activator: it is a causal probe for separating pathway amplitude, developmental timing, and tissue-specific outcomes. This guide interprets recent tongue-development findings and translates them into better assay design, controls, and preclinical decision-making.

EPZ5676: DOT1L Inhibitor Workflow Guide

2026-09-09

EPZ5676 connects SAM-competitive DOT1L biochemistry with H3K79 methylation inhibition, MLL-rearranged leukemia studies, and emerging multiple myeloma assays. This workflow guide emphasizes concentration design, orthogonal validation, combination testing with lenalidomide, and practical troubleshooting.

PTGER4–HDAC Signaling in Rectal Epithelial Cells

2026-09-09

The reference study identifies a mechanistic link between mesenchymal stromal cell-derived PGE2, epithelial PTGER4 signaling, class IIa HDAC phosphorylation, and SPINK4 mRNA regulation in rectal organoids. Its integrated organoid, co-culture, imaging, transcript, and protein analyses provide a framework for studying epithelial repair pathways while highlighting the importance of preserving phosphorylation states during biochemical workflows.

BMS 309403: A Practical FABP4 Inhibitor Workflow

2026-09-08

BMS 309403 provides a selective, mechanism-focused way to interrogate FABP4 in macrophage lipid handling, foam cell formation, and inflammatory signaling. This workflow connects dose-response cell assays with atherosclerosis and metabolic disease models while emphasizing solubility, controls, and interpretation.

Axitinib (AG 013736): From Potency to Translation

2026-09-08

A mechanistic and strategic guide to using Axitinib (AG 013736) in VEGF pathway studies, angiogenesis inhibition assays, and tumor xenograft research—while separating pathway control from broader drug-response effects.

Neuritin, ER Stress, and NF-κB After SAH

2026-09-07

The reference study maps three endoplasmic-reticulum-stress inflammatory branches to neuroinflammation and neuronal apoptosis during early brain injury after subarachnoid hemorrhage. Its main contribution is showing that neuritin overexpression suppresses convergent NF-κB signaling across these branches, offering a mechanistic framework for studying neuroprotection without equating preclinical pathway modulation with clinical efficacy.

Nanobody-TurboID Maps the CD38 Surfaceome

2026-09-05

The reference study introduces nanobody-targeted TurboID (NBID) to profile proteins spatially associated with CD38 in living cells. Its results identify adhesion, extracellular-matrix, lipid-raft, and cadherin-associated networks that connect CD38 to tumor-cell transendothelial migration, while establishing a transferable strategy for studying native cell-surface protein neighborhoods.

Gastrin I (Human): Mechanism and Research Uses

2026-09-05

Gastrin I is a human Gastrin I peptide that activates CCK2 receptor-linked gastric acid secretion biology. The B5358 material supports controlled gastric acid secretion pathway research, receptor signaling experiments, and gastrointestinal physiology studies when its physical properties and model limitations are documented.

Vincristine sulfate: Applied Research Workflows

2026-09-04

Build reproducible vincristine sulfate assays around microtubule dynamics, exposure control, and orthogonal readouts. This guide connects cell-based screening, mechanistic validation, and troubleshooting with practical workflows for cancer research.

Carbapenemase Spread in CREC Across Guangdong Hospitals

2026-09-04

Lithium, Rab11a, and Exosomal Wnt10a in Osteogenesis

2026-09-03

Chen and colleagues identify a mechanistic link between lithium exposure, Rab11a-dependent exosomal Wnt10a secretion, and Wnt/β-catenin activation in bone mesenchymal stem cells. Their Li-Exo-loaded GelMA hydrogel strategy improved osteogenic activity and bone repair relative to untreated BMSC exosomes, while also highlighting important questions about dosing, extracellular-vesicle standardization, and clinical translation.

2',7'-Dichlorofluorescein diacetate: ROS Workflow

2026-09-03

Build a practical intracellular ROS measurement workflow with 2',7'-Dichlorofluorescein diacetate, from fresh DMSO stocks through microscopy, flow cytometry, and plate-based readouts. The approach also shows how this broad redox indicator can complement ROS-responsive nanocarrier studies while avoiding claims of chemical specificity.

AO/PI Double Staining Kit: Cell Death Workflows

2026-09-02

The AO/PI Double Staining Kit converts membrane integrity and nuclear morphology into a rapid three-state readout for viable, apoptotic, and necrotic cells. This article shows how to deploy it after drug treatment, rare-cell isolation, or sample-quality checks while controlling dye balance, imaging bias, and interpretation limits.

SmD2 Acetylation Rewires PARP Inhibitor Response

2026-09-02

A 2024 Nature Communications study identifies SmD2 acetylation as a regulatory link between core spliceosome activity, BRCA1/FANC cassette exons, and PARP inhibitor sensitivity in hepatocellular carcinoma. The findings support a preclinical strategy that combines HDAC-directed treatment with PARP inhibition, particularly in tumors retaining functional BRCA genes.